What is the appropriate medication regimen for vertiginous dizziness in the emergency department?

Medication for Vertiginous Dizziness in the Emergency Department

For acute vertiginous dizziness in the ER, limit vestibular suppressants (antihistamines like meclizine or benzodiazepines like diazepam) to short-term symptomatic relief only—maximum 3 days—and only for severe nausea/vomiting, not as primary treatment for the underlying vertigo itself. 1, 2

Primary Treatment Approach: Diagnosis-Driven, Not Medication-Driven

The critical error in the ER is reflexively prescribing vestibular suppressants without establishing the underlying cause. Your medication strategy must follow this algorithm:

Step 1: Determine the Temporal Pattern

• Acute Vestibular Syndrome (AVS): Continuous vertigo lasting hours to days with nystagmus
• Episodic Vestibular Syndrome: Recurrent episodes, each <24 hours
• Triggered positional vertigo: Symptoms provoked by head position changes

Step 2: Match Treatment to Diagnosis

For BPPV (most common cause):

• DO NOT prescribe vestibular suppressants as primary treatment 1
• DO perform Epley maneuver immediately—this is the definitive treatment 3
• Vestibular suppressants show no evidence of effectiveness for BPPV and may impair central compensation 1
• Exception: Short-term antiemetics (ondansetron, promethazine) for severe nausea only in patients refusing repositioning maneuvers 1

For Vestibular Neuritis/Labyrinthitis:

• Short-term vestibular suppressants (≤3 days maximum) 2
  • Meclizine 25-50 mg or diazepam 2-5 mg for acute symptom control
  • Antiemetics (ondansetron 4-8 mg) for nausea/vomiting
• Consider short-term corticosteroids (methylprednisolone 100mg daily × 3 days, then taper) 3
• Critical caveat: Prolonged use of vestibular suppressants (>3 days) interferes with vestibular compensation and delays recovery 1, 4

For Ménière's Disease:

• Acute attack: Limited vestibular suppressants during the attack only 5
  • Benzodiazepines (diazepam 2-10 mg) or antihistamines (meclizine 25-50 mg)
  • Antiemetics for nausea (promethazine 12.5-25 mg, ondansetron 4-8 mg)
• NOT for prevention—these are for symptom control during attacks only 5

For Vestibular Migraine:

• Avoid vestibular suppressants as primary treatment
• Treat as migraine: NSAIDs, triptans if appropriate 6
• Consider antiemetics for nausea

Specific Medication Classes and Their Limitations

Antihistamines (Meclizine, Diphenhydramine)

• Suppress central emetic center for nausea/vomiting
• Do not treat the underlying vertigo mechanism 1
• Sedation impairs examination and delays compensation
• Maximum 3 days use 2

Benzodiazepines (Diazepam, Clonazepam)

• Reduce subjective spinning sensation
• Major harm: Interfere with central vestibular compensation 1, 4
• Significant risk: Drug dependence with prolonged use 5
• Reserve for severe acute symptoms only, maximum 3 days

Anticholinergics (Scopolamine)

• Reduce neural mismatch in motion sickness
• Side effects: blurred vision, dry mouth, urinary retention, sedation
• Not commonly recommended for acute vertigo in ER due to side-effect profile 5

Antiemetics (Ondansetron, Promethazine)

• Appropriate use: Symptomatic treatment of nausea/vomiting
• Ondansetron preferred (fewer sedating effects than promethazine)
• Does not treat vertigo itself 1

Critical Pitfalls to Avoid

1. Prescribing vestibular suppressants without performing Dix-Hallpike testing: This misses BPPV, which requires physical maneuvers, not medication 3

2. Prolonged vestibular suppressant use (>3 days): Delays vestibular compensation and prolongs recovery 1, 2

3. Using CT or vestibular suppressants to "rule out stroke": Neither is appropriate—perform HINTS examination (if trained) or obtain MRI with DWI if central cause suspected 3, 7

4. Treating medication side effects as "persistent vertigo": Vestibular suppressants themselves cause dizziness and disequilibrium 1

5. Missing stroke in AVS: 25-75% of posterior circulation strokes present as isolated vertigo without focal neurologic signs 7. Vestibular suppressants can mask examination findings 1

Evidence Quality Context

The guidelines against routine vestibular suppressant use are based on Grade C evidence (observational studies), but the recommendation is strong because the preponderance of benefit favors harm avoidance 1. There is no evidence these medications treat the underlying pathology, and clear evidence they impair recovery mechanisms.

The 2023 GRACE-3 guidelines emphasize that physical examination and maneuvers are superior to medication for most causes of acute vertigo in the ED 3.

Discharge Strategy

• If prescribing vestibular suppressants: Explicitly limit to 3 days maximum with clear instructions
• Arrange follow-up within 1 month to confirm symptom resolution 1
• Educate that medication is for symptom control only, not cure
• Provide fall precautions given sedation risk and underlying balance impairment